Know Cancer

or
forgot password

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Screening


N/A
32 Years
38 Years
Not Enrolling
Female
Cervical Cancer, Cervical Intraepithelial Neoplasia

Thank you

Trial Information

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Screening


Inclusion Criteria:



- Women aged 32-38 years old

- Attending the Swedish population-based organised cervical screening program

Exclusion Criteria:

- Not providing informed consent

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Screening

Outcome Measure:

Incidence of CIN2/CIN3+ lesions (which includes invasive cancers and in situ adenocarcinomas) found by subsequent screening (i.e. after the enrollment screening round and its associated follow-up).

Outcome Time Frame:

On average 4 years post baseline

Principal Investigator

Joakim Dillner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Malmo University Hospital, Lund University

Authority:

Sweden: Regional Ethical Review Board

Study ID:

3824-B00-05XAC

NCT ID:

NCT00479375

Start Date:

May 1997

Completion Date:

May 2007

Related Keywords:

  • Cervical Cancer
  • Cervical Intraepithelial Neoplasia
  • screening
  • human papillomavirus
  • Neoplasms
  • Uterine Cervical Neoplasms
  • Cervical Intraepithelial Neoplasia
  • Carcinoma in Situ

Name

Location